论文信息 - Using Noncoated andHeparin-Coated Extracorporeal Circuits* - 字舞流文

Using Noncoated andHeparin-Coated Extracorporeal Circuits*

J. Maessen | M. Dentener | P. Weerwind | M. Bouma

[1] P. Venge,et al. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. , 2008, Artificial organs.

[2] M. Oppermann,et al. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis. , 1993, Clinical nephrology.

[3] R. Wakusawa,et al. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[4] W. Baumgartner,et al. Heparin-coated bypass circuits reduce pulmonary injury. , 1993, The Annals of thoracic surgery.

[5] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[6] A. Galloway,et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. , 1995, The Annals of thoracic surgery.

[7] P. Venge,et al. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. , 1994, Scandinavian journal of thoracic and cardiovascular surgery.

[8] R. Ulevitch,et al. CD14: cell surface receptor and differentiation marker. , 1993, Immunology today.